Search
Search Results
##search.searchResults.foundPlural##
-
THE ROLE OF INFECTION IN THE PATHOGENESIS OF VASO-OCCLUSIVE CRISIS IN PATIENTS WITH SICKLE CELL DISEASE.
5136PDF: 1314HTML: 2741Cover letter: 192 -
The diagnostic pitfalls of mucormycosis
897PDF: 714HTML: 249 -
Editorial : INTRODUCING MEDITERRANEAN JOURNAL OF HEMATOLOGY AND INFECTIOUS DISEASES
3316PDF: 582HTML: 655 -
GILTERITINIB (XOSPATA ®) IN TURKEY: EARLY ACCESS PROGRAM RESULTS Gilteritinib (XOSPATA ®) in Turkey
1411PDF: 898Suppl. Files: 453HTML: 234 -
PROCALCITONIN AS A BIOMARKER OF BACTERIAL INFECTION IN SICKLE CELL VASO-OCCLUSIVE CRISIS.
2062PDF: 1042HTML: 15650COVER LETTER: 187 -
The Outcome of Six Patients with COVID-19 Infection and Multiple Myeloma. A Case Series and Literature Review COVID-19 in Multiple Myeloma patients
965PDF: 358HTML: 191 -
HIV-ASSOCIATED VENOUS THROMBOEMBOLISM
3867PDF: 1469HTML: 8513 -
Tacrolimus Associated Posterior Reversible Encephalopathy Syndrome – A Case Series and Review
3541PDF: 1478HTML: 4387CoverLetter: 184Figure1: 194 -
SIMPLE PERIPHERAL BLOOD SMEAR FINDINGS OF COVID-19 PATIENTS PROVIDE INFORMATION ABOUT THE SEVERITY OF THE DISEASE AND THE DURATION OF HOSPITAL STAY. Peripheral blood smear and COVID-19 severity.
3238PDF: 1081HTML: 432 -
PRACTICAL RECOMMENDATIONS FOR THE MANAGEMENT OF PATIENTS WITH ITP DURING THE COVID-19 PANDEMIC Recommendation for ITP management during COVID
2473PDF: 920HTML: 523 -
SARS-CoV-2 (COVID-19) and Chronic Myeloid Leukemia (CML): a case report and review of ABL kinase involvement in viral infection CML and COVID-19
3254PDF: 1529HTML: 420 -
SUSTAINED REMISSION IN AN ELDERLY PATIENT WITH ACUTE MYELOID LEUKEMIA FOLLOWING GILTERITINIB TREATMENT AS THIRD-LINE SALVAGE THERAPY Long-lasting disease remission with third line therapy with gilteritinib
934PDF: 510HTML: 191 -
Postpandemic influenza A/H1N1pdm09 is still causing severe perinatal complications
1339PDF: 981HTML: 2002Cover letter: 200 -
COVID-19 IN CHILDREN AND ADOLESCENT: CHARACTERISTICS AND SPECIFICITIES IN IMMUNOCOMPETENT AND ONCOHEMATOLOGICAL PATIENTS COVID-19 IN CHILDREN AND ADOLESCENT.
2256PDF: 931HTML: 300 -
NOVEL DRUGS IN FOLLICULAR LYMPHOMA
4308PDF: 1487HTML: 1547Untitled: 225 -
Antivirals and monoclonal antibody combination therapy in haematological patients in the omicron era Antiviral and monoclonal Antibodies in Haematological Patients in the omicron era
1277PDF: 933HTML: 90 -
Focusing On A Unique Innate Memory Cell Population Of Natural Killer Cells In The Fight Against COVID-19: Harnessing The Ubiquity Of Cytomegalovirus Exposure Memory Cell Population Of Natural Killer Cells in COVID-19 and Cytomegalovirus Exposure
1153PDF: 911HTML: 287 -
ACUTE LUNG INJURY COMPLICATING BLOOD TRANSFUSION IN POST-PARTUM HEMORRHAGE: INCIDENCE AND RISK FACTORS.
2431PDF: 1225HTML: 3597Acute lung injury complicating blood transfusion in post-partum hemorrhage: incidence and risk factors.: 407 -
DIAGNOSIS OF MALARIA INFECTION WITH OR WITHOUT DISEASE
3598PDF: 1106HTML: 23335 -
HODGKIN LYMPHOMA IN CHILDREN: A 16-YEAR EXPERIENCE AT THE CHILDREN’S WELFARE TEACHING HOSPITAL OF BAGHDAD, IRAQ
1028PDF: 924Suppl. Files: 592HTML: 82 -
Toxic epidermal necrolysis associated with severe cytomegalovirus infection in a patient on regular hemodialysis.
1747PDF: 529HTML: 16968Figure 4: 166Figure 3: 140Figure 2: 145Figure 1: 177 -
Monocyte HLA-Dr Expression to Monitor Immune Response and Potential Infection Risks Following Vaso-Occlusive Crises in Patients with Sickle Cell Anemia Monocyte HLA-DR expression in SCA patients
689PDF: 527HTML: 209 -
PARASITIC INFECTIONS IN HEMATOPOIETIC STEM CELL TRANSPLANTATION
3678PDF: 1234HTML: 3883Untitled: 209Untitled: 258







